Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Familial anetoderma is an extremely rare genetic skin disease characterized by loss of elastin tissue leading to localized areas of flaccid skin and a family history of the disorder.
Features include very common findings: Papule; and common findings: High, narrow palate, Generalized joint hypermobility, Excessive inward curve of the lower back (lumbar hyperlordosis), and Abnormal tibia morphology and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 2 | Generalized joint hypermobility, Excessive inward curve of the lower back (lumbar hyperlordosis) |
Biomarker and diagnostic research for familial anetoderma has been reported in the published literature.
Phenotype severity distribution: 1 very common feature, 5 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for familial anetoderma.
36 publications have been identified in PubMed for familial anetoderma. Research spans Review / Meta-Analysis (26%), Case Report / Case Series (26%), and Epidemiology / Natural History (23%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 9 | 26% |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 3:44 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Skin |
1 |
Papule |
Head and neck | 1 | High, narrow palate |
9 |
26% |
Disease patterns and progression | 8 | 23% |
Laboratory research | 4 | 11% |
Testing and diagnosis research | 3 | 9% |
Clinical study results | 2 | 6% |
Xu Y (2026). [PMID: 41622658](https://pubmed.ncbi.nlm.nih.gov/41622658/). *Am J Case Rep*. [Case Report / Case Series]
Takai Y (2026). [PMID: 42018115](https://pubmed.ncbi.nlm.nih.gov/42018115/). *Jpn J Ophthalmol*. [Epidemiology / Natural History]
Arias S (2026). [PMID: 41643098](https://pubmed.ncbi.nlm.nih.gov/41643098/). *Medicina (B Aires)*. [Case Report / Case Series]
Wang J (2026). [PMID: 41863617](https://pubmed.ncbi.nlm.nih.gov/41863617/). *Mol Genet Genomics*. [Basic Science / Preclinical]
Iwaki Y (2026). [PMID: 41553591](https://pubmed.ncbi.nlm.nih.gov/41553591/). *Doc Ophthalmol*. [Basic Science / Preclinical]
Krasniakova M (2026). [PMID: 41888298](https://pubmed.ncbi.nlm.nih.gov/41888298/). *Sci Rep*. [Clinical Trial Publication]
Phiri P (2026). [PMID: 41843216](https://pubmed.ncbi.nlm.nih.gov/41843216/). *Int Ophthalmol*. [Review / Meta-Analysis]
Fragiotta S (2026). [PMID: 41248230](https://pubmed.ncbi.nlm.nih.gov/41248230/). *Retina*. [Review / Meta-Analysis]
Jonas JB (2025). [PMID: 40067096](https://pubmed.ncbi.nlm.nih.gov/40067096/). *Acta Ophthalmol*. [Epidemiology / Natural History]
Preiksaitiene E (2025). [PMID: 41011040](https://pubmed.ncbi.nlm.nih.gov/41011040/). *Medicina (Kaunas)*. [Case Report / Case Series]